Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,279 | 447 | 98.5% |
| Education | $95.99 | 13 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $843.73 | 62 | $0 (2022) |
| GlaxoSmithKline, LLC. | $826.57 | 63 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $738.39 | 40 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $611.77 | 58 | $0 (2022) |
| Lilly USA, LLC | $526.38 | 55 | $0 (2020) |
| PFIZER INC. | $481.40 | 40 | $0 (2022) |
| Novo Nordisk Inc | $434.81 | 27 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $271.74 | 21 | $0 (2019) |
| ABBVIE INC. | $200.02 | 10 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $181.47 | 11 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $205.06 | 3 | Dexcom, Inc. ($129.10) |
| 2023 | $32.20 | 1 | GlaxoSmithKline, LLC. ($32.20) |
| 2022 | $365.83 | 18 | Amgen Inc. ($62.40) |
| 2021 | $535.71 | 26 | Novo Nordisk Inc ($113.95) |
| 2020 | $417.85 | 23 | GlaxoSmithKline, LLC. ($102.46) |
| 2019 | $1,484 | 103 | Amgen Inc. ($264.25) |
| 2018 | $1,903 | 166 | GlaxoSmithKline, LLC. ($351.85) |
| 2017 | $1,432 | 120 | Janssen Pharmaceuticals, Inc ($264.35) |
All Payment Transactions
460 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/20/2024 | Dexcom, Inc. | DEXCOM G7 GSS (161) (Medical Supply) | Food and Beverage | In-kind items and services | $129.10 | General |
| Category: Endocrinology | ||||||
| 03/25/2024 | Philips North America LLC | (6346) Intrasight Mobile (Device) | Food and Beverage | Cash or cash equivalent | $37.98 | General |
| Category: Medical Device | ||||||
| 03/25/2024 | Philips North America LLC | (6346) Intrasight Mobile (Device) | Food and Beverage | Cash or cash equivalent | $37.98 | General |
| Category: Medical Device | ||||||
| 09/12/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX, BEXSERO | Food and Beverage | In-kind items and services | $32.20 | General |
| Category: RESPIRATORY | ||||||
| 06/15/2022 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $34.53 | General |
| Category: Inflammation | ||||||
| 06/03/2022 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $28.35 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/25/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/25/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: NEUROSCIENCE | ||||||
| 04/19/2022 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $27.87 | General |
| Category: Inflammation | ||||||
| 04/16/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: NEUROSCIENCE | ||||||
| 04/06/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: RESPIRATORY | ||||||
| 04/03/2022 | Antares Pharma, Inc. | NOCDURNA (Drug), XYOSTED | Food and Beverage | In-kind items and services | $25.53 | General |
| Category: NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS | ||||||
| 03/15/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: RESPIRATORY | ||||||
| 02/24/2022 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 02/23/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.19 | General |
| Category: Cardiovascular | ||||||
| 02/15/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: RESPIRATORY | ||||||
| 02/10/2022 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $12.47 | General |
| Category: Obesity | ||||||
| 02/07/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.09 | General |
| Category: DIABETES | ||||||
| 02/01/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $22.51 | General |
| Category: NEUROSCIENCE | ||||||
| 02/01/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.03 | General |
| 01/31/2022 | Phadia US Inc. | ImmunoCAP (Device) | Food and Beverage | Cash or cash equivalent | $19.72 | General |
| Category: Allergy/Immunology | ||||||
| 01/06/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/21/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: RESPIRATORY | ||||||
| 12/20/2021 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $21.99 | General |
| Category: Bone Health | ||||||
| 12/09/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT, SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $25.76 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,607 | 2,719 | $620,957 | $210,542 |
| 2022 | 18 | 1,526 | 2,694 | $596,188 | $211,614 |
| 2021 | 20 | 1,773 | 3,054 | $603,410 | $235,552 |
| 2020 | 19 | 1,834 | 2,885 | $584,062 | $203,557 |
All Medicare Procedures & Services
77 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 617 | 1,427 | $390,998 | $117,545 | 30.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 319 | 319 | $95,062 | $40,584 | 42.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 154 | 186 | $34,782 | $11,006 | 31.6% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 30 | 34 | $20,128 | $7,257 | 36.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 24 | 24 | $9,144 | $6,755 | 73.9% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 67 | 67 | $7,579 | $4,970 | 65.6% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 24 | 25 | $11,000 | $4,059 | 36.9% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 54 | 74 | $10,138 | $3,036 | 29.9% |
| 91322 | Sarscov2 vac 50 mcg/0.5ml im | Office | 2023 | 22 | 22 | $3,850 | $3,003 | 78.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 13 | 13 | $5,694 | $2,130 | 37.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 64 | 64 | $3,618 | $1,932 | 53.4% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 11 | 11 | $4,675 | $1,806 | 38.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 15 | 15 | $5,550 | $1,768 | 31.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 27 | 150 | $9,300 | $1,478 | 15.9% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 22 | 22 | $1,870 | $858.90 | 45.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 70 | 73 | $3,212 | $746.85 | 23.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 24 | 24 | $1,386 | $736.08 | 53.1% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 13 | 16 | $1,696 | $495.15 | 29.2% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 13 | 13 | $715.00 | $223.68 | 31.3% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 24 | 140 | $560.00 | $151.72 | 27.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 659 | 1,644 | $429,084 | $137,946 | 32.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 289 | 289 | $76,874 | $37,548 | 48.8% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 35 | 38 | $21,014 | $8,254 | 39.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 113 | 124 | $22,816 | $7,241 | 31.7% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 79 | 83 | $7,384 | $5,758 | 78.0% |
About Dr. Steve Stringfellow, MD
Dr. Steve Stringfellow, MD is a Internal Medicine healthcare provider based in Tacoma, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1699795161.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steve Stringfellow, MD has received a total of $6,375 in payments from pharmaceutical and medical device companies, with $205.06 received in 2024. These payments were reported across 460 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($6,279).
As a Medicare-enrolled provider, Stringfellow has provided services to 6,740 Medicare beneficiaries, totaling 11,352 services with total Medicare billing of $861,265. Data is available for 4 years (2020–2023), covering 77 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Tacoma, WA
- Active Since 07/20/2006
- Last Updated 09/10/2010
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1699795161
Products in Payments
- XARELTO (Drug) $519.28
- Prolia (Biological) $313.56
- CHANTIX (Drug) $253.69
- JARDIANCE (Drug) $234.60
- TRELEGY ELLIPTA (Drug) $231.66
- EVENITY (Biological) $203.09
- STIOLTO RESPIMAT (Drug) $202.07
- TRULICITY (Drug) $183.80
- Aimovig (Biological) $175.05
- JANUVIA (Drug) $174.48
- BREO (Drug) $172.45
- TRADJENTA (Drug) $159.12
- Ozempic (Drug) $139.66
- ANORO (Drug) $136.76
- DEXCOM G7 GSS (161) (Medical Supply) $129.10
- SPIRIVA RESPIMAT (Drug) $128.74
- PREVNAR - 13 (Biological) $127.83
- EMGALITY (Drug) $123.53
- INVOKANA (Drug) $92.49
- STIOLTO (Drug) $91.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Tacoma
John Sun, Md, MD
Internal Medicine — Payments: $305,883
Dr. Charles Minn, M.d, M.D
Internal Medicine — Payments: $66,588
Dr. Royce Morrison, M.d, M.D
Internal Medicine — Payments: $55,477
Lillian Wang, Md, MD
Internal Medicine — Payments: $25,238
Daniel Ginsberg, Md, MD
Internal Medicine — Payments: $13,981
Weiqiang Gao, M.d, M.D
Internal Medicine — Payments: $13,645